|
1
|
Zarate C, Duman RS, Liu G, Sartori S,
Quiroz J and Murck H: New paradigms for treatment-resistant
depression. Ann NY Acad Sci. 1292:21–31. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Naughton M, Clarke G, O'Leary OF, Cryan JF
and Dinan TG: A review of ketamine in affective disorders: Current
evidence of clinical efficacy, limitations of use and pre-clinical
evidence on proposed mechanisms of action. J Affect Disord.
156:24–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kavalali ET and Monteggia LM: How does
ketamine elicit a rapid antidepressant response. Curr Opin
Pharmacol. 20:35–39. 2015. View Article : Google Scholar
|
|
4
|
Jha AK, Bhardwaj N, Yaddanapudi S, Sharma
RK and Mahajan JK: A randomized study of surgical site infiltration
with bupivacaine or ketamine for pain relief in children following
cleft palate repair. Paediatr Anaesth. 23:401–406. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tawfic QA: A review of the use of ketamine
in pain management. J Opioid Manag. 9:379–388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ricaurte GA and McCann UD: Recognition and
management of complications of new recreational drug use. Lancet.
365:2137–2145. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang YC, Chen SK and Lin CM: Breaking the
drug addiction cycle is not easy in ketamine abusers. Int J Urol.
17:496author reply 497. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jansen KL and Darracot-Cankovic R: The
nonmedical use of ketamine, part two: A review of problem use and
dependence. J Psychoactive Drugs. 33:151–158. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lim DK: Ketamine associated psychedelic
effects and dependence. Singapore Med J. 44:31–34. 2003.PubMed/NCBI
|
|
10
|
Slikker W Jr, Liu F, Rainosek SW,
Patterson TA, Sadovova N, Hanig JP, Paule MG and Wang C:
Ketamine-induced toxicity in neurons differentiated from neural
stem cells. Mol Neurobiol. 52:959–969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gray T and Dass M: Ketamine cystitis: An
emerging diagnostic and therapeutic challenge. Br J Hosp Med
(Lond). 73:576–579. 2012. View Article : Google Scholar
|
|
12
|
Gu D, Huang J, Yin Y, Shan Z, Zheng S and
Wu P: Long-term ketamine abuse induces cystitis in rats by
impairing the bladder epithelial barrier. Mol Biol Rep.
41:7313–7322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shahani R, Streutker C, Dickson B and
Stewart RJ: Ketamine-associated ulcerative cystitis: A new clinical
entity. Urology. 69:810–812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH,
Wong S, Tse JM, Lau FL, Yiu MK and Man CW: The destruction of the
lower urinary tract by ketamine abuse: A new syndrome. BJU Int.
102:1616–1622. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Colebunders B and Van Erps P: Cystitis due
to the use of ketamine as a recreational drug: A case report. J Med
Case Reports. 2:2192008. View Article : Google Scholar :
|
|
16
|
Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW,
Man CW, Ma WK, Chui KL, Yiu MK, Chan YC, et al: 'Street
ketamine'-associated bladder dysfunction: A report of ten cases.
Hong Kong Med J. 13:311–313. 2007.PubMed/NCBI
|
|
17
|
Chen CH, Lee MH, Chen YC and Lin MF:
Ketamine-snorting associated cystitis. J Formos Med Assoc.
110:787–791. 2011. View Article : Google Scholar
|
|
18
|
Cheung RY, Lee JH, Chan SS, Liu DW and
Choy KW: A pilot study of urine cytokines in ketamine-associated
lower urinary tract symptoms. Int Urogynecol J Pelvic Floor
Dysfunct. 25:1715–1719. 2014. View Article : Google Scholar
|
|
19
|
Smart C, Kabir M and Pati J: Treatment of
ketamine-associated cystitis with chondroitin sulphate. Br J Nurs.
22:S4S6S8–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chuang SM, Liu KM, Li YL, Jang MY, Lee HH,
Wu WJ, Chang WC, Levin RM and Juan YS: Dual involvements of
cyclooxygenase and nitric oxide synthase expressions in
ketamine-induced ulcerative cystitis in rat bladder. Neurourol
Urodyn. 32:1137–1143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu D, Huang J, Shan Z, Yin Y, Zheng S and
Wu P: Effects of long-term ketamine administration on rat bladder
protein levels: A proteomic investigation using two-dimensional
difference gel electrophoresis system. Int J Urol. 20:1024–1031.
2013.PubMed/NCBI
|
|
22
|
Baker SC, Stahlschmidt J, Oxley J, Hinley
J, Eardley I, Marsh F, Gillatt D, Fulford S and Southgate J: Nerve
hyperplasia: A unique feature of ketamine cystitis. Acta
Neuropathol Commun. 1:642013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jhang JF, Hsu YH, Jiang YH and Kuo HC:
Elevated serum IgE may be associated with development of ketamine
cystitis. J Urol. 192:1249–1256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mami I, Tavernier Q, Bouvier N, Aboukamis
R, Desbuissons G, Rabant M, Poindessous V, Laurent-Puig P, Beaune
P, Tharaux PL, et al: A novel extrinsic pathway for the unfolded
protein response in the kidney. J Am Soc Nephrol. 27:2670–2683.
2016.PubMed/NCBI
|
|
25
|
de Oliveira L, Spiazzi CM, Bortolin T,
Canever L, Petronilho F, Mina FG, Dal-Pizzol F, Quevedo J and Zugno
AI: Different sub-anesthetic doses of ketamine increase oxidative
stress in the brain of rats. Prog Neuropsychopharmacol Biol
Psychiatry. 33:1003–1008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Toma JG, Akhavan M, Fernandes KJ,
Barnabé-Heider F, Sadikot A, Kaplan DR and Miller FD: Isolation of
multipotent adult stem cells from the dermis of mammalian skin. Nat
Cell Biol. 3:778–784. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fernandes KJ, McKenzie IA, Mill P, Smith
KM, Akhavan M, Barnabé-Heider F, Biernaskie J, Junek A, Kobayashi
NR, Toma JG, et al: A dermal niche for multipotent adult
skin-derived precursor cells. Nat Cell Biol. 6:1082–1093. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang HI, Chen SK, Ling QD, Chien CC, Liu
HT and Chan SH: Multilineage differentiation potential of
fibroblast-like stromal cells derived from human skin. Tissue Eng
Part A. 16:1491–1501. 2010. View Article : Google Scholar
|
|
29
|
Wang CC, Weng TI, Wu ET, Wu MH, Yang RS
and Liu SH: Involvement of interleukin-6-regulated nitric oxide
synthase in hemorrhagic cystitis and impaired bladder contractions
in young rats induced by acrolein, a urinary metabolite of
cyclophosphamide. Toxicol Sci. 131:302–310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moore KA, Sklerov J, Levine B and Jacobs
AJ: Urine concentrations of ketamine and norketamine following
illegal consumption. J Anal Toxicol. 25:583–588. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ho YH, Wang CC, Hsiao YT, Ko WK and Wu SM:
Analysis of ten abused drugs in urine by large volume sample
stacking-sweeping capillary electrophoresis with an experimental
design strategy. J Chromatogr A. 1295:136–141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tam YH, Ng CF, Pang KK, Yee CH, Chu WC,
Leung VY, Wong GL, Wong VW, Chan HL and Lai PB: One-stop clinic for
ketamine-associated uropathy: Report on service delivery model,
patients' characteristics and non-invasive investigations at
baseline by a cross-sectional study in a prospective cohort of 318
teenagers and young adults. BJU Int. 114:754–760. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ng CM, Ma WK, To KC and Yiu MK: The
Chinese version of the pelvic pain and urgency/frequency symptom
scale: A useful assessment tool for street-ketamine abusers with
lower urinary tract symptoms. Hong Kong Med J. 18:123–130.
2012.PubMed/NCBI
|
|
34
|
Chung SD, Wang CC and Kuo HC: Augmentation
enterocystoplasty is effective in relieving refractory
ketamine-related bladder pain. Neurourol Urodyn. 33:1207–1211.
2014. View Article : Google Scholar
|
|
35
|
Lin HC, Lee HS, Chiueh TS, Lin YC, Lin HA,
Lin YC, Cha TL and Meng E: Histopathological assessment of
inflammation and expression of inflammatory markers in patients
with ketamine-induced cystitis. Mol Med Rep. 11:2421–2428. 2015.
View Article : Google Scholar :
|
|
36
|
Shen CH, Wang ST, Lee YR, Liu SY, Li YZ,
Wu JD, Chen YJ and Liu YW: Biological effect of ketamine in
urothelial cell lines and global gene expression analysis in the
bladders of ketamine injected mice. Mol Med Rep. 11:887–895. 2015.
View Article : Google Scholar
|
|
37
|
Andersson KE and Arner A: Urinary bladder
contraction and relaxation: Physiology and pathophysiology. Physiol
Rev. 84:935–986. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ibeawuchi CU, Ajayi OI and Ebeigbe AB:
Vascular effect of ketamine in isolated rabbit aortic smooth
muscle. Niger J Physiol Sci. 23:85–88. 2008.
|
|
39
|
Ozturk AM, Ergun MA, Demir T, Gungor I,
Yilmaz A and Kaya K: Ketamine is toxic to chondrocyte cell
cultures. Bone Joint J. 96-B:989–994. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chang HC, Chen TL and Chen RM:
Cytoskeleton interruption in human hepatoma HepG2 cells induced by
ketamine occurs possibly through suppression of calcium
mobilization and mitochondrial function. Drug Metab Dispos.
37:24–31. 2009. View Article : Google Scholar
|
|
41
|
Ma J, Nishimura H, Fogo A, Kon V, Inagami
T and Ichikawa I: Accelerated fibrosis and collagen deposition
develop in the renal interstitium of angiotensin type 2 receptor
null mutant mice during ureteral obstruction. Kidney Int.
53:937–944. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Juan YS, Lee YL, Long CY, Wong JH, Jang
MY, Lu JH, Wu WJ, Huang YS, Chang WC and Chuang SM: Translocation
of NF-κB and expression of cyclooxygenase-2 are enhanced by
ketamine-induced ulcerative cystitis in rat bladder. Am J Pathol.
185:2269–2285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Song M, Yu HY, Chun JY, Shin DM, Song SH,
Choo MS and Song YS: The fibrosis of ketamine, a noncompetitive
N-methyl-d-aspartic acid receptor antagonist dose-dependent change
in a ketamine-induced cystitis rat model. Drug Chem Toxicol.
39:206–212. 2016. View Article : Google Scholar
|
|
44
|
Chen CZ and Raghunath M: Focus on
collagen: In vitro systems to study fibrogenesis and antifibrosis
state of the art. Fibrogenesis Tissue Repair. 2:72009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Borg BB, Seetharam A, Subramanian V, Basha
HI, Lisker-Melman M, Korenblat K, Anderson CD, Shenoy S, Chapman
WC, Crippin JS, et al: Immune response to extra-cellular matrix
collagen in chronic hepatitis C-induced liver fibrosis. Liver
Transpl. 17:814–823. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Challa AA, Vukmirovic M, Blackmon J and
Stefanovic B: Withaferin-A reduces type I collagen expression in
vitro and inhibits development of myocardial fibrosis in vivo. PLoS
One. 7:e429892012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Muñoz-Cánoves P, Scheele C, Pedersen BK
and Serrano AL: Interleukin-6 myokine signaling in skeletal muscle:
A double-edged sword. FEBS J. 280:4131–4148. 2013. View Article : Google Scholar
|
|
48
|
Yang C, Jiang RY, Shen J, Hong T, Liu N,
Ding LC, Wang DM, Chen LJ, Xu B and Zhu B: Ketamine attenuates the
lipopolysaccharide-induced inflammatory response in cultured N2a
cells. Mol Med Rep. 8:217–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tang SH, Yu JG, Li JJ and Sun JY:
Neuroprotective effect of ketamine on acute spinal cord injury in
rats. Genet Mol Res. 14:3551–3556. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lee GL, Wu JY, Yeh CC and Kuo CC: TLR4
induces CREB-mediated IL-6 production via upregulation of F-spondin
to promote vascular smooth muscle cell migration. Biochem Biophys
Res Commun. 473:1205–1210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hiram R, Rizcallah E, Marouan S, Sirois C,
Sirois M, Morin C, Fortin S and Rousseau E: Resolvin E1 normalizes
contractility, Ca2+ sensitivity and smooth muscle cell
migration rate in TNF-α-and IL-6-pretreated human pulmonary
arteries. Am J Physiol Lung Cell Mol Physiol. 309:L776–L788.
2015.PubMed/NCBI
|
|
52
|
Cascella R, Ragazzo M, Strafella C,
Missiroli F, Borgiani P, Angelucci F, Marsella LT, Cusumano A,
Novelli G, Ricci F, et al: Age-related macular degeneration:
Insights into inflammatory genes. J Ophthalmol.
582842:2014.PubMed/NCBI
|
|
53
|
Ye ZW, Zhang J, Townsend DM and Tew KD:
Oxidative stress, redox regulation and diseases of cellular
differentiation. Biochim Biophys Acta. 1850:1607–1621. 2015.
View Article : Google Scholar :
|
|
54
|
Dijkstra G, Blokzijl H, Bok L, Homan M,
van Goor H, Faber KN, Jansen PL and Moshage H: Opposite effect of
oxidative stress on inducible nitric oxide synthase and haem
oxygenase-1 expression in intestinal inflammation:
Anti-inflammatory effect of carbon monoxide. J Pathol. 204:296–303.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Soyer T, Boybeyi Ö and Atasoy P: Selective
inhibition of nitric oxide synthase causes increased muscle
thickness in rat esophagus. J Pediatr Surg. 50:1112–1114. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Al-Azemi M, Refaat B, Amer S, Ola B,
Chapman N and Ledger W: The expression of inducible nitric oxide
synthase in the human fallopian tube during the menstrual cycle and
in ectopic pregnancy. Fertil Steril. 94:833–840. 2010. View Article : Google Scholar
|
|
57
|
Dobrek Ł and Thor PJ: Bladder urotoxicity
pathophysiology induced by the oxazaphosphorine alkylating agents
and its chemoprevention. Postepy Hig Med Dosw Online. 66:592–602.
2012. View Article : Google Scholar
|
|
58
|
Yilmaz N, Emmungil H, Gucenmez S, Ozen G,
Yildiz F, Balkarli A, Kimyon G, Coskun BN, Dogan I, Pamuk ON, et
al: Incidence of cyclophosphamide-induced urotoxicity and
protective effect of mesna in rheumatic diseases. J Rheumatol.
42:1661–1666. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Gray KJ, Engelmann UH, Johnson EH and
Fishman IJ: Evaluation of misoprostol cytoprotection of the bladder
with cyclophosphamide (Cytoxan) therapy. J Urol. 136:497–500. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang N, Yu HY, Shen XF, Gao ZQ, Yang C,
Yang JJ and Zhang GF: The rapid antidepressant effect of ketamine
in rats is associated with downregulation of pro-inflammatory
cytokines in the hippocampus. Ups J Med Sci. 120:241–248. 2015.
View Article : Google Scholar
|
|
61
|
Souza-Fiho MV, Lima MV, Pompeu MM, Ballejo
G, Cunha FQ and Ribeiro RdeA: Involvement of nitric oxide in the
pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Am J
Pathol. 150:247–256. 1997.PubMed/NCBI
|
|
62
|
Ozguven AA, Yılmaz O, Taneli F, Ulman C,
Vatansever S and Onag A: Protective effect of ketamine against
hemorrhagic cystitis in rats receiving ifosfamide. Indian J
Pharmacol. 46:147–151. 2014. View Article : Google Scholar : PubMed/NCBI
|
